Search Results - "NICCOLAI, LINDA M."

Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008-2014 by McClung, Nancy M, Gargano, Julia W, Bennett, Nancy M, Niccolai, Linda M, Abdullah, Nasreen, Griffin, Marie R, Park, Ina U, Cleveland, Angela A, Querec, Troy D, Unger, Elizabeth R, Markowitz, Lauri E

“…The impact of human papillomavirus (HPV) vaccination has been observed in the United States through declining cervical precancer incidence in young women. To…”
Get full text

Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review by Ellingson, Mallory K., Sheikha, Hassan, Nyhan, Kate, Oliveira, Carlos R., Niccolai, Linda M.

“…Human papillomavirus (HPV) vaccines work by preventing infections prior to natural exposure. Thus, it is likely more effective at younger ages, and it is…”
Get full text

Failure to Complete Multidose Vaccine Series in Early Childhood by Michels, Sarah Y, Niccolai, Linda M, Hadler, James L, Freeman, Rain E, Albers, Alexandria N, Glanz, Jason M, Daley, Matthew F, Newcomer, Sophia R

“…Most early childhood immunizations require 3 to 4 doses to achieve optimal protection. Our objective was to identify factors associated with starting but not…”
Get full text

Racial/Ethnic and Poverty Disparities in Human Papillomavirus Vaccination Completion by Niccolai, Linda M., PhD, Mehta, Niti R., MPH, Hadler, James L., MD, MPH

“…Background Two vaccines against human papillomavirus (HPV), a necessary cause of cervical cancer, are currently licensed and recommended for routine…”
Get full text

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012 by Hariri, Susan, Bennett, Nancy M, Niccolai, Linda M, Schafer, Sean, Park, Ina U, Bloch, Karen C, Unger, Elizabeth R, Whitney, Erin, Julian, Pamela, Scahill, Mary W, Abdullah, Nasreen, Levine, Diane, Johnson, Michelle L, Steinau, Martin, Markowitz, Lauri E

“…Abstract Background Prevention of pre-invasive cervical lesions is an important benefit of HPV vaccines, but demonstrating impact on these lesions is impeded…”
Get full text

SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA by Ehrlich, Hanna Y, Harizaj, Adora, Campbell, Lauren, Colt, McKenzie, Yuan, Karen, Rabatsky-Ehr, Therese, Weinberger, Daniel M, Leung, Vivian, Niccolai, Linda M, Parikh, Sunil

“…Nursing homes house populations that are highly vulnerable to coronavirus disease. Point prevalence surveys (PPSs) provide information on the severe acute…”
Get full text

Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015 by Cleveland, Angela A., Gargano, Julia W., Park, Ina U., Griffin, Marie R., Niccolai, Linda M., Powell, Melissa, Bennett, Nancy M., Saadeh, Kayla, Pemmaraju, Manideepthi, Higgins, Kyle, Ehlers, Sara, Scahill, Mary, Johnson Jones, Michelle L., Querec, Troy, Markowitz, Lauri E., Unger, Elizabeth R.

“…Primary prevention through the use of human papillomavirus (HPV) vaccination is expected to impact both cervical intraepithelial neoplasia (CIN) and…”
Get full text

Suboptimal uptake of meningococcal vaccines among older adolescents: Barriers, solutions, and future research directions by Niccolai, Linda M., Hansen, Caitlin E.

“…Over the past 15 y, several vaccines have been added to the recommended immunization schedule for adolescents in the United States. In addition to annual…”
Get full text

Shale gas activity and increased rates of sexually transmitted infections in Ohio, 2000-2016 by Deziel, Nicole C, Humeau, Zoe, Elliott, Elise G, Warren, Joshua L, Niccolai, Linda M

“…The growing shale gas ("fracking") industry depends on a mobile workforce, whose influx could have social impacts on host communities. Sexually transmitted…”
Get full text

HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States by Hariri, Susan, Unger, Elizabeth R, Schafer, Sean, Niccolai, Linda M, Park, Ina U, Bloch, Karen C, Bennett, Nancy M, Steinau, Martin, Johnson, Michelle L, Markowitz, Lauri E

“…Two currently available vaccines targeting human papillomavirus (HPV) types 16 and 18 could prevent 70% of cervical cancers and 50% of high-grade cervical…”
Get full text

Patterns of recommended vaccine receipt among women ages 24-45 years: a cross-sectional analysis by Ellingson, Mallory K, Oliveira, Carlos R, Sheth, Sangini S, Sullivan, Erin L, Torres, Ashlynn, Shapiro, Eugene D, Niccolai, Linda M

“…Vaccine receipt among mid-adults remains low, with only one quarter of adults being up to date for all recommended vaccines. It is important to understand the…”
Get full text

Effectiveness of HPV vaccine by age at vaccination and number of doses: protocol for a population-based matched case–control study by Oliveira, Carlos R, Ortiz, Anette Michelle, Sheth, Sangini S, Shapiro, Eugene D, Niccolai, Linda M

“…IntroductionIn 2006, the first human papillomavirus (HPV) vaccine was approved by the Food and Drug Administration in the USA based on pre-licensure clinical…”
Get full text

Practice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage: A Systematic Review by Niccolai, Linda M, Hansen, Caitlin E

“…Vaccines against human papillomavirus (HPV) are recommended for routine use in adolescents aged 11 to 12 years in the United States, but uptake remains…”
Get more information

Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012 by Hariri, Susan, Markowitz, Lauri E, Bennett, Nancy M, Niccolai, Linda M, Schafer, Sean, Bloch, Karen, Park, Ina U, Scahill, Mary W, Julian, Pamela, Abdullah, Nasreen, Levine, Diane, Whitney, Erin, Unger, Elizabeth R, Steinau, Martin, Bauer, Heidi M, Meek, James, Hadler, James, Sosa, Lynn, Powell, Suzanne E, Johnson, Michelle L

“…In 2007, five Emerging Infections Program (EIP) sites were funded to determine the feasibility of establishing a population-based surveillance system for…”
Get full text

Knowledge and beliefs regarding cervical cancer screening and HPV vaccination among urban and rural women in León, Nicaragua by Rees, Hannah D, Lombardo, Alexandra R, Tangoren, Caroline G, Meyers, Sara J, Muppala, Vishnu R, Niccolai, Linda M

“…In Nicaragua, cervical cancer is the leading cause of cancer-related death for women ages 15-44, yet access to the HPV vaccine is limited to those with…”
Get full text

Lack of School Requirements and Clinician Recommendations for Human Papillomavirus Vaccination by Niccolai, Linda M., North, Anna L., Footman, Alison, Hansen, Caitlin E.

“…Background: A strong recommendation from a clinician is one of the best predictors of human papillomavirus (HPV) vaccination among adolescents, yet many…”
Get full text

Monitoring HPV vaccine impact on cervical disease: Status and future directions for the era of cervical cancer elimination by Oliveira, Carlos R., Niccolai, Linda M.

“…Post-licensure monitoring of the impact of HPV vaccines is critical to track the progress being made toward cervical cancer elimination and to identify areas…”
Get full text

Factors Associated With Receipt of Meningococcal B Vaccine Among United States Adolescents, National Immunization Survey-Teen, 2017–2018 by Hansen, Caitlin E., Niccolai, Linda M.

“…In this study, we evaluated factors associated with receipt of meningococcal serogroup B (MenB) vaccine among adolescents in the United States. We used public…”
Get full text

A world without cervical cancer is within our reach by Giuliano, Anna R., Niccolai, Linda M.

Get full text

State-Level Voting Patterns and Adolescent Vaccination Coverage in the United States, 2014 by Bernstein, Steven, North, Anna, Schwartz, Jason, Niccolai, Linda M

“…To examine state-level associations between voting patterns and adolescent coverage for at least 1 dose of human papillomavirus (HPV), tetanus-containing…”
Get full text